Dr. Reddy's Laboratories Limited (BOM:500124)
India · Delayed Price · Currency is INR 1,277.05
-2.20 (-0.17%)
At close: Jun 16, 2026
Dr. Reddy's Laboratories Employees
Dr. Reddy's Laboratories had 27,527 employees as of March 31, 2026. The number of employees decreased by 284 or -1.02% compared to the previous year.
Employees
27,527
Change (1Y)
-284
Growth (1Y)
-1.02%
Revenue / Employee
12.20M INR
Profits / Employee
1.56M INR
Market Cap
1.06T
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 27,527 | -284 | -1.02% |
| Mar 31, 2025 | 27,811 | 763 | 2.82% |
| Mar 31, 2024 | 27,048 | 1,185 | 4.58% |
| Mar 31, 2023 | 25,863 | 1,068 | 4.31% |
| Mar 31, 2022 | 24,795 | 2,056 | 9.04% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Lupin | 24,006 |
| Torrent Pharmaceuticals | 18,258 |
| J. B. Chemicals & Pharmaceuticals | 5,602 |
| Jubilant Pharmova | 5,547 |
| Granules India | 4,066 |
| Caplin Point Laboratories | 3,966 |
| Abbott India | 3,659 |
| GlaxoSmithKline Pharmaceuticals | 3,103 |
Dr. Reddy's Laboratories News
- 18 hours ago - Dr. Reddy's Laboratories (RDY) Secures License for XACDURO Distribution - GuruFocus
- 19 hours ago - Innoviva announces distribution, licensing agreement with Dr. Reddy’s - TheFly
- 1 day ago - Dr. Reddy's Laboratories (RDY) Faces 15% Drop Amid Market Movements - GuruFocus
- 2 days ago - Stocks to watch on June 15: Aurobindo Pharma, Patanjali Foods, Cyient, Dr Reddy's, JSW Energy, Aditya Birla Capital and more - Business Upturn
- 2 days ago - Dr. Reddy's (RDY) Launches Generic Bosutinib Tablets in the U.S. - GuruFocus
- 2 days ago - Dr. Reddy’s announces first-to-market launch of Bosutinib Tablets 400mg - TheFly
- 3 days ago - Dr. Reddy's Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United States - Business Wire
- 4 days ago - Dr. Reddy's launches Bosutinib Tablets 400mg in the United States - Business Upturn